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ABSTRACT
Many are using wearable fitness trackers to assess energy expenditure (EE). Fitness trackers have been
demonstrated to overestimate EE. Few studies have investigated EE tracking in the diabetic population.
PURPOSE: To compare energy expenditure estimation for two fitness trackers and a gold-standard in a
type 2 diabetic (T2DM) versus a healthy (H) population. METHODS: 24 participants (10 T2DM; 14 H)
were recruited and met inclusion criteria. At initial visit, subjects completed treadmill walking while
connected to a metabolic cart (gold-standard) with continuous monitoring via face mask and 2 activity
trackers standardized in place one on each wrist. Participants walked on a treadmill for two phases: Phase
A consisted of a warm-up followed by 10 minutes data collection at a self-selected walking pace (SSWP).
Phase B included 10 minutes walking at 40-60% heart rate reserve. Total energy expenditure (EE) was
collected from each device during the 10-minute data collection periods. Baseline descriptive data and
Pearson correlation were determined. Mann-Whitney U test was performed to compare EE from the goldstandard in both groups for phase A and B. Friedman’s followed by Wilcoxon post hoc tests along with
Bland-Altman analyses were utilized to explore EE measurements in all devices for groups in phase A and
B. RESULTS: Results from the gold standard indicated no difference in EE between T2DM and H in
phase A or B. (Phase A: T2DM=50.2+/- 10.5 Kcal, H=47.0+/-11.8 Kcal; Phase B: T2DM=74.0+/-20.5 Kcal
vs. H=79.9+/-22.6 Kcal). In exploratory comparisons, T2DM and H both demonstrated no significant
difference in EE between tracker 1 and 2 (76.21+/-27.3 Kcal vs. 79.4+/-20.5 Kcal) while both trackers
showed a significant difference compared to the gold-standard (48.3+/-11.1 Kcal) in phase A. For phase
B, all devices were significantly different (Tracker 1: 113.25+/-32.1 Kcal; Tracker 2: 95.1+/-22.12 Kcal;
Gold-standard: 77.45+/-21.5 Kcal). CONCLUSION: TD2M demonstrated no difference in EE versus
healthy individuals during a SSWP or walking at a moderate intensity. Based on exploratory analyses,
more variance between groups was noted utilizing activity trackers. Additionally, the trackers
demonstrate a tendency to overestimate EE in both groups despite standardization of placement and
intensity of walking. Health care professionals should use this knowledge in recommendations during
exercise prescription.
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